Delivery Order SPE2DB22D2206-SPE2DB24FJV24
Award Date
8/16/24
Potential Completion Date
8/19/24
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $4,647.12 firm-fixed-price contract provides for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The contract has an ultimate completion date of September 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of medications, medical supplies, and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $4,647.12 firm-fixed-price delivery order is for the supply of 4,566,077,237 units of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The award has an ultimate completion date of October 11, 2024 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,995.64 Firm Fixed Price Delivery Order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The $13,856.75 firm-fixed-price delivery order contract has an ultimate completion date of July 18, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation for this award. This contract is likely part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the procurement of MONOVISC 88 MG/4 ML SYRINGE 4ML. The $10,103.93 firm-fixed price delivery order contract has a completion date of February 4, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that supplies medical products to federal government agencies, including the military healthcare system. This award is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Monovisc 88 mg/4 ml syringe, a medical product. The contract has a firm fixed price of $10,459.04 and a period of performance ending on July 30, 2024. The contract is a delivery order and does not have a set-aside designation. AmerisourceBergen, through its Corporate Office Division, has been awarded numerous federal contracts and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML medical products. The $4,793.76 firm fixed price delivery order has an ultimate completion date of September 10, 2024. Amerisourcebergen has been awarded multiple federal contracts and indefinite delivery contracts (IDCs) by the DLA and other agencies, such as the Department of Justice Federal Bureau...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,121.82 firm fixed-price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with an ultimate completion date of April 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,230.33 firm fixed-price delivery order is for the medical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has an ultimate completion date of December 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $4,876.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract has an ultimate completion date of September 19, 2024 and is a Firm Fixed Price Delivery Order. This award is not associated with a set-aside program. As a supplier to various government agencies, Amerisourcebergen holds several...